This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. TEE helps cardiologists by providing highly detailed images of the heart and its internal structures.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. Zane was diagnosed during a routine ultrasound at 20 weeks’ gestation and his mom, Kayla, was immediately referred to the Colorado Fetal Care Center (CFCC) at Childrens Hospital Colorado.
Ultrasound techniques currently used in echocardiography uses frame rates from 30-150 frames/s. This limits its temporal resolution for very short lived events, especially in pediatric and congenital heart disease with faster heart rates compared to adults [1]. J Am Coll Cardiol. 2024 Jan 2;83(1):63-81. doi: 10.1016/j.jacc.2023.10.025.
This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.
Background Axillary arterial access (AAA) in pediatric heart catheterizations is undervalued. Methods We retrospectively reviewed children with congenital heart diseases (CHDs) who received trans-axillary arterial catheterizations between January 2019 and February 2023.
A bedside cardiac ultrasound was normal. Accelerated ventricular rhythm in children: a review and report of a case with congenital heart disease 3. There was apparently no syncope and he had no bony injuries, but he did complain of left sided chest pain. His chest was tender. He wrote: "ECG 1 - shows wide ???IVCD IVCD type rhythm ??
During echocardiography, a transducer transmits the ultrasound beam towards the heart. This becomes more difficult in complex congenital heart diseases where the cardiac chamber positions and size may vary. Subcostal view is a favourite view of pediatric echocardiographers. Interatrial septum is best imaged in this view.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content